AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort

Bibliographic Details
Published in:Rheumatoid arthritis – biological DMARDs
Main Authors: Vasilenko, E., Samigullina, R.R., Mazurov, V.I., Trofimov, E.A., Gaydukova, I.Z.
Format: Conference Object
Language:unknown
Published: BMJ Publishing Group Ltd and European League Against Rheumatism 2018
Subjects:
Online Access:http://dx.doi.org/10.1136/annrheumdis-2018-eular.6211
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2018-eular.6211
id crjcrbmj:10.1136/annrheumdis-2018-eular.6211
record_format openpolar
spelling crjcrbmj:10.1136/annrheumdis-2018-eular.6211 2024-02-11T10:08:17+01:00 AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort Vasilenko, E. Samigullina, R.R. Mazurov, V.I. Trofimov, E.A. Gaydukova, I.Z. 2018 http://dx.doi.org/10.1136/annrheumdis-2018-eular.6211 https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2018-eular.6211 unknown BMJ Publishing Group Ltd and European League Against Rheumatism Rheumatoid arthritis – biological DMARDs proceedings-article 2018 crjcrbmj https://doi.org/10.1136/annrheumdis-2018-eular.6211 2024-01-26T10:13:34Z Conference Object Russian North The BMJ Rheumatoid arthritis – biological DMARDs 1379.2 1380
institution Open Polar
collection The BMJ
op_collection_id crjcrbmj
language unknown
format Conference Object
author Vasilenko, E.
Samigullina, R.R.
Mazurov, V.I.
Trofimov, E.A.
Gaydukova, I.Z.
spellingShingle Vasilenko, E.
Samigullina, R.R.
Mazurov, V.I.
Trofimov, E.A.
Gaydukova, I.Z.
AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
author_facet Vasilenko, E.
Samigullina, R.R.
Mazurov, V.I.
Trofimov, E.A.
Gaydukova, I.Z.
author_sort Vasilenko, E.
title AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
title_short AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
title_full AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
title_fullStr AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
title_full_unstemmed AB0433 Tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
title_sort ab0433 tnf-inhibitors and anti-b- cell treatment in patients with rheumatoid arthritis. real-world data from the russian north-western biological treatment cohort
publisher BMJ Publishing Group Ltd and European League Against Rheumatism
publishDate 2018
url http://dx.doi.org/10.1136/annrheumdis-2018-eular.6211
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2018-eular.6211
genre Russian North
genre_facet Russian North
op_source Rheumatoid arthritis – biological DMARDs
op_doi https://doi.org/10.1136/annrheumdis-2018-eular.6211
container_title Rheumatoid arthritis – biological DMARDs
container_start_page 1379.2
op_container_end_page 1380
_version_ 1790607361182793728